Clinical Trials Logo

Filter by:
NCT ID: NCT04265755 Completed - Migraine Clinical Trials

Biomarker and Genetic Predictors of Erenumab Treatment Response

INTERROGATE
Start date: October 26, 2020
Phase: Phase 4
Study type: Interventional

To explore the relationship between clinical response to erenumab and genetic biomarkers

NCT ID: NCT04263649 Completed - Clinical trials for Peripherally Inserted Central Catheter

Prospective Observational Study of the Power PICC Family of Devices and Accessories

Start date: June 18, 2020
Phase:
Study type: Observational

Post-market, observational study to collect prospective data related to the safety and performance of the Power PICC family of devices and its accessories in a real-world setting.

NCT ID: NCT04263493 Completed - Clinical trials for Achilles Tendon Rupture

Delayed Loading Following Repair of a Ruptured Achilles Tendon

DELOAT
Start date: May 20, 2020
Phase: N/A
Study type: Interventional

The purpose of the study is to investigate if delayed loading following surgical treated Achilles tendon rupture influence the clinical outcome and muscle and tendon structure after one year. The investigators hypothesize that delaying the gradual introduction of loading in the initial 26 weeks may reduce the heel-rise deficit (primary outcome) and thus improve the clinical outcome one year after surgery (primary endpoint).

NCT ID: NCT04260646 Completed - Clinical trials for Incontinence, Urinary

Alarm Treatment for Combined Enuresis and Daytime Urinary Incontinence in Children

ABDE
Start date: May 1, 2017
Phase: N/A
Study type: Interventional

The aim is to examine whether alarm therapy in addition to urotherapy can have a beneficial effect in treating urinary incontinence children with combined daytime incontinence and enuresis. The study will include children who suffers for combined daytime incontinence and enuresis and referred to one of the pediatric departments were offed to participate. Participants are randomized to 8 weeks treatment with either enuresis alarm and timer watch assist urotherapy or solely timer watch assisted urotherapy.

NCT ID: NCT04260074 Completed - Clinical trials for Head and Neck Cancer

Epigenetic Changes in Head and Neck Cancer

Start date: March 11, 2020
Phase:
Study type: Observational

With this study, the investigators will investigate the epigenetic changes, which may contribute to the development of head and neck squamous cell carcinomas.

NCT ID: NCT04260035 Completed - Pain Clinical Trials

The Effects of a Long-lasting Infusion of Vasoactive Intestinal Peptide (VIP) in Episodic Migraine Patients

Start date: May 19, 2020
Phase: N/A
Study type: Interventional

Vasoactive intestinal peptide (VIP) is a peptide of 28 amino acid residues that belongs to the glucagon/secretin superfamily of peptides. Along with other neuropeptides, such as calcitonin gene-related peptide (CGRP) and pituitary adenylate cyclase-activating polypeptide (PACAP), it is released from the trigeminal afferents and exerts a strong vasodilating activity on the cranial vasculature. Especially, it shares 70% structure with PACAP and acts on the same receptors. But, unlike it, VIP cannot induce a long-lasting vasodilation and has a modest capability to induce migraine attacks. Whether it may induce migraine-like attacks in migraine patients, as a twenty-minute infusion of PACAP, is unknown.

NCT ID: NCT04259658 Completed - Cancer Clinical Trials

Histopathologic Effect of Calcium Electroporation on Cancer in the Skin

CAEP-B
Start date: April 20, 2020
Phase: Phase 2
Study type: Interventional

In this phase II study we investigate the effect of calcium electroporation on cancer in the skin investigated by histopathology.

NCT ID: NCT04258904 Completed - Type 1 Diabetes Clinical Trials

Prevention of Skin Problems With Diabetes Devices in Pediatric Patients

Start date: March 10, 2020
Phase: N/A
Study type: Interventional

A Cluster-controlled Intervention Trial regarding Prevention of Dermatological Complications towards use of Continuous glucose monitoring and insulin pumps in pediatric patients with Type 1 Diabetes. The patients will be followed prospectively with visits every 3rd month for the first year of initiation of device. Besides a standardized treatment plan if dermatological complications evolve, will be used.

NCT ID: NCT04258176 Completed - Multimorbidity Clinical Trials

A Multidisciplinary Outpatient Pathway

Start date: August 15, 2018
Phase:
Study type: Observational [Patient Registry]

Patients with complex chronic multiple illnesses constitute an increasing challenge and more evidence-based knowledge of effective practice is required. In Denmark and the rest of the world, improved health care, public health, and increased focus on early diagnosis have led to increases in life expectancy resulting in a growing population of older people living with multiple long-term conditions (multimorbidity). Today, every fourth Dane suffers from more than one concomitant chronic or severe disease, estimated to rise to 60% for those over 65 years. National and international health care is organised and targeted as specialised, mono-diagnostic efforts for single diseases leading to lack of coordination and failure to integrate multidisciplinary patient trajectories. Danish research shows that general practice is challenged by insufficient collaboration between professionals involved in the treatment. Despite this, there exists limited evidence of initiatives aiming to improve care for multimorbid patients. This study aims to: 1. identify chronic multimorbid patients and to analyse their use of two or more outpatient clinics, their general use of health care utilisations and their disease pattern and characteristics (Cross-sectional study using national registers). 2. develop an innovative organisational structure around a multidisciplinary outpatient pathway for multimorbid patients and to pilot-test it (feasibility study) 3. phase-III test a multidisciplinary outpatient pathway and to preliminarily evaluate the effects in patients and health professionals and on resource utilisations (effect study)

NCT ID: NCT04257344 Completed - Clinical trials for Surgery--Complications

Use of Wearables for Early Detection of Complications After Major Acute Abdominal Surgery

Start date: October 1, 2019
Phase:
Study type: Observational

The purpose of the study is to investigate whether glucose profile, sleep disturbances and heart rate variability measured with wearable devices is associated with postoperative recovery and complications within 30 days after major emergency abdominal surgery. The study is designed as an explorative, prospective cohort study. 40 patients undergoing major emergency abdominal surgery at Zealand's University Hospital Køge are included in the study, and inclusion occurs within 24 hours of end of surgery. Patients will be followed for 30 days, and three scheduled study visits are planned during follow up at postoperative day 10, 20 and 30. Glucose is measured continuously with a wearable subcutaneous sensor (Dexcom G6). Glucose readings are validated in the perioperative setting using blood glucose measurements obtained with standard finger-pricks 3-5 times a day during hospitalization. Actigraphy is used for assessing sleep- and activity patterns for the full study period. Heart rate variation is measured with a compact Holter monitor. Furthermore, the study assesses patient-reported quality of recovery, glucose metabolism, nutritional status and mobility. Various data on demographics, peri- and postoperative data will be extracted from the electronic patient chart.